United States District Court, S.D. California
(1) DENYING DARWIN'S MOTION FOR RECONSIDERATION (DOC. 146) (2) DENYING DARWIN'S SUPPLEMENTAL MOTION FOR ECONSIDERATION (DOC. 153)
CYNATHIA BASHANT, District Judge.
On May 13, 2014, the court granted Plaintiff Millennium Laboratories, Inc.'s motion for summary judgment. Doc. 112. The court found that "the Ameritox third amended complaint and the Calloway counterclaim create a potential for coverage' under the terms of the policy." Order Grant Summ. J. 9:20-22.
On June 9, 2014, Defendant filed a Motion for Clarification and/or Reconsideration of the court's order granting Plaintiff's summary judgment motion. Doc. 146. Defendant stated the "motion does not seek to reargue issues that were clearly decided by the Order." Def.'s Mot. Recons. 2:5-6. Instead, Defendant seeks clarification as to whether (1) the court considered extrinsic evidence beyond that
- 1 - 12-cv-2742 BAS (KSC) tendered to Defendant, and (2) whether consideration of that evidence was in clear error.
Defendant does not cite to a statutory or precedential basis for its motion directly. However, Carroll v. Nakatani, 342 F.3d 934 (9th Cir. 2003), cited in their motion as the applicable legal standard, concerns motions for reconsideration raised under Federal Rules of Civil Procedure Rule 59(e). Def.'s Mot. Recons. 3:9-20. Thus, Defendant's so-called "motion for clarification and/or reconsideration" will be treated as a motion to alter or amend judgment under Rule 59(e).
The Court considered this motion on the papers submitted and without oral argument. See Civ. L.R. 7.1(d.1). For the following reasons, the Court DENIES Defendants' motion. Doc. 146.
I. LEGAL STANDARD
Once judgment has been entered, reconsideration may be sought by filing a motion under either Federal Rule of Civil Procedure 59(e) (motion to alter or amend a judgment) or Federal Rule of Civil Procedure 60(b) (motion for relief from judgment). See Hinton v. P. Enter., 5 F.3d 391, 395 (9th Cir. 1993).
"Although Rule 59(e) permits a district court to reconsider and amend a previous order, the rule offers an extraordinary remedy, to be used sparingly in the interests of finality and conservation of judicial resources." Kona Enters., Inc. v. Estate of Bishop, 229 F.3d 877, 890 (9th Cir. 2000) (internal quotation marks omitted). "Indeed, a motion for reconsideration should not be granted, absent highly unusual circumstances, unless the district court is presented with newly discovered evidence, committed clear error, or if there is an intervening change in the controlling law." Id. (quoting 389 Orange St. Partners v. Arnold, 179 F.3d 656, 665 (9th Cir. 1999)) (internal quotation marks omitted). Further, a motion for reconsideration may not be used to raise arguments or present evidence for the first time when they could reasonably have been raised earlier in the litigation. Id. It does not give parties a "second bite at the apple." See id. Finally, "after thoughts" or "shifting of ground" do not constitute an appropriate basis for reconsideration. Ausmus v. Lexington Ins. Co., No. 08-CV-2342-L, 2009 WL 2058549, at *2 (S.D. Cal. July 15, 2009).
Defendant seeks clarification as to the basis for the court's finding that the Ameritox Third Amended Complaint and the Calloway counterclaim created a "potential for coverage" such that its duty to defend Plaintiff was triggered. As the court noted in its order, "the insured need only show that the underlying claim may fall within policy coverage; the insurer must prove it cannot.' Montrose Chem. [ Corp. v. Superior Court, ] 6 Cal.4th [287, ] 300 [(1993)]." Order Grant Summ. J. 9:23-24. The court unambiguously applies this legal standard only to the complaint and the counterclaim themselves. In relevant part, the court stated:
When Millennium Labs tendered its claim for coverage of the Ameritox action under the policy, it included the text of ¶ 28, stating that "Millennium's actions have evidenced its intent to do harm to Ameritox in the marketplace at any cost, and Millennium has instructed its sales reps to do the same." (Doc No. 73-4, Ex. 20, sealed.) When Millennium Labs tendered its claim for coverage of the Calloway action, it included Calloway's allegation that Millennium "engaged in a concerted plan to attack' Calloway... through its marketing efforts" as well as Calloway's discovery responses mentioning the PowerPoint presentation as a basis for the counterclaim. (See Doc No. 73-4, Ex. 21, sealed; see also Doc. No. 75-10, Fowler Decl. Ex. D, Calloway Answer, at 18.) Based on this information, Darwin could have determined that the underlying actions fell within the policy's coverage of claims based on disparagement of an organization's goods, product or services. Accordingly, the Court concludes that Millennium Labs has satisfied its burden to "show that the underlying claim may fall Within policy coverage." Montrose Chem. [ Corp. v. Superior Court, ] 6 Cal.4th [287, ] 300 [(1993)].
Order Grant Summ. J. 9:25-10:10. Insofar as any clarification is required, the court later and separately addressed the extrinsic evidence-and therefore implicitly isolated it from the rationale for the court's decision.
The extrinsic evidence is, however, relevant in two ways. First, the legal standard for "potential for coverage" requires an insurer to prove the facts giving rise to the duty cannot possibly give rise to a coverable claim. In light of the extrinsic evidence, it would be impossible for Defendant to meet this burden, as all material elements for a disparagement claim are met here. Defendant contends this evidence was not available at the time of tender; Defendant is wrong. All the underlying acts giving rise to potential disparagement liability had already ...